Invited Speakers
2018 | ||
24.01.2018 | Albert Bräuning, PhD German Federal Institute for Risk Assessment (BfR) |
Food Safety at the German Federal Institute for Risk Assessment (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
05.12.2018 | Klaus Mörike, MD University Hospital Tübingen |
Clinical Studies – Design and Realization (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
2017 | ||
24.05.2017 | Joerg Albert, MD Robert-Bosch-Hospital |
Physiology and pathophysiology of the digestive system (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
31.05.2017 | Christian Schäfer, MD Robert-Bosch-Hospital |
Physiology and pathophysiology of the liver (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
31.05.2017 | Jun J. Yang, Ph.D. St. Jude Children's Research Hospital |
Pharmacogenomics of Thiopurines and Precision Medicine: From Genomics to Clinical Actions |
14.06.2017 | Godehard Friedel, MD Robert-Bosch-Hospital - Schillerhoehe |
Physiology and pathophysiology of the lungs (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
21.06.2017 | Andreas Hartkopf, MD University Hospital Tuebingen |
Physiology and pathophysiology of the breast (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”) |
28.06.2017 | Kilian Rapp, MD Robert-Bosch-Hospital |
Physiological Specialties in Elderly Patients (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
05.07.2017 | Peter Ong, MD Robert-Bosch-Hospital |
Physiology and pathophysiology of the cardiovascular System (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
13.07.2017 | Robert Feil, PhD University of Tuebingen |
Seeing is believing: Combining biochemistry and mouse genetics to visualize physiology, pathophysiology and pharmacology |
12.07.2017 | Martin Kimmel, MD Robert-Bosch-Hospital |
Physiology and pathophysiology of the kidneys (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
19.07.2017 | Andreas Nüssler, MD University of Tuebingen |
Cell culture approaches towards 3D micro-organ Engineering (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) |
18.09.2017 | Sven Glaesker, MD University Hospital Brussels |
Molecular and morphological pathogenesis in von Hippel-Lindau (VHL) disease |
08.11.2017 | Klaus Moerike, MD University Hospital Tuebingen |
Arzneimitteltherapie kardialer Arrhythmien (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
15.11.2017 | Robert Lukowski, PhD University Hospital Tuebingen |
The NO-cGMP system: Implications for disease biology and therapy |
22.11.2017 | Reinhold Kerb, MD CRS Clinical Research GmbH |
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
29.11.2017 | Peter Muenzel University of Tuebingen |
Gifte und Vergiftungen (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
08.12.2017 | Carsten Gruellich, MD NCT -National Center for Tumor Diseases Heidelberg Medical Oncology |
Molekulare Heterogenität und therapiegetriebene Evolution des Nierenzellkarzinoms |
11.12.2017 | Markus Morkel, MD Charité - University Hospital Berlin |
Organoids as a tool to assess oncogene characteristics and cancer signaling networks |
13.12.2017 | Robert Juette, PhD Institute of the History of Medicine, Robert Bosch Stiftung |
Der Placebo Effekt: Past and Present (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”) |
2016 | ||
04.05.2016 | Walter Aulitzky, MD Robert-Bosch-Hospital |
Introduction – Basic and Clinical Aspects (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”) |
22.06.2016 | Michael Schwarz, MD University Hospital Tuebingen |
Mechanisms of Tumor Promotion (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”) |
23.06.2016 | Elfriede Nößner, PhD Helmholtz- Center Munich |
“Enriched-in-renal-carcinoma dendritic cells” (ercDCs) are unique macrophages with a gene signature indicative of immune escape |
29.06.2016 | German Ott, MD Robert-Bosch-Hospital |
Tumor Pathology – Where Morphology Meets Molecular Genetics (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”) |
29.06.2016 | Joachim Orth, PhD University of Freiburg |
Regulation of bone cell differentiations by G protein deamidating toxins |
13.07.2016 | Michael Dengler, PhD The Walter & Eliza Hall Institute of Medical Research, Victoria, Australia |
Control of apoptosis by the Bcl-2 family: Molecular mechanisms and therapeutic potential (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”) |
29.07.2016 | Hannelore Daniel, PhD Technical University Munich (TUM) |
We are all individuals – I am not |
03.08.2016 | Daniela Stöhr, PhD University of Stuttgart |
Downregulation of TRAIL receptor expression in multicellular tumor spheroids: a reason for TRAIL resistance? |
26.10.2016 | Christina Justenhoven, PhD Bioscientia – Insititute of Medical Diagnostics, Ingelheim |
Analysis of DNA Variations (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”) |
23.11.2016 | Marius Ueffing, PhD Medical Proteome Center Tübingen |
Proteomics – From basic approaches to clinical applications |
20.12.2016 | Barbara Seliger, PhD Martin Luther University, Halle |
How tumor cells escape immune resistance |
21.12.2016 | H.P. Rodemann, PhD University Hospital Tübingen |
Soft Dkills I: Good scientific practice (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”) |
2015 | ||
03.02.2015 | Edgar Serfling, PhD University of Wuerzburg |
NFATc1 Controls the Fate of Lymphocytes by Controlling their Metabolic Capacity |
04.02.2015 | Peter Münzel, PhD University Hospital Tuebingen |
Gifte und Vergiftungen |
11.02.2015 | Klaus Mörike, MD University Hospital Tuebingen |
Drug Therapy in Special Populations: Pregnancy and Old Age |
18.02.2015 | Christian Harteneck, PhD University Hospital Tuebingen |
Pharmacological Mudulation of Ion Channels |
16.03.2015 | Jörn Lausen, PhD Georg-Speyer-Haus, Frankfurt |
Epigenetic mechanisms in hematopoiesis as molecular therapeutic targets |
24.04.2015 | Monica Campillos, PhD Helmholtz-Zentrum München |
From pertubations of mammalian organisms to phenotypes |
04.11.2015 | Marieke Coenen, PhD and Maroeska te Loo, PhD Radboud University Medical Center, Nijmegen |
Pharmacogenetics of inflammatory bowel disease and childhood cancer: from research to diagnostics |
09.12.2015 | Klaus Mörike, MD University Hospital Tübingen |
Clinical Studies – Design and Realization |
2014 | ||
22.01.2014 | Thomas Wheeler-Schilling, PhD University Hospital Tübingen |
What a scientist should know beyond science |
28.01.2014 | Steven de Jong, PhD Dept. of Medical Oncology, University Medical Center Groningen |
Targeting novel pathways to overcome platinum-based resistance in testicular and ovarian cancer |
20.02.2014 | Dik van Gent, MD, PhD Erasmus Universiteit Rotterdam, Netherlands |
Exploiting the DNA damage response for personalized tumor treatment |
09.05.2014 | Gerhard Treiber, MD Gastro Zentrum Hirslanden Klinik, Schänisweg, Aarau, Switzerland |
Physiology and Pathophysiology of Oesophagus and Stomach |
14.05.2014 | Christian Schäfer, MD Gastroenterology, Robert-Bosch-Hospital, Stuttgart |
Physiology and Pathophysiology of the liver |
23.05.2014 | Ali Yilmaz, MD Cardiology, University Hospital Münster |
Physiology and Pathophysiology of the Cardiovascular System |
11.06.2014 | Godehard Friedel, MD Klinik Schillerhöhe |
Physiology and Pathophysiology of the lungs |
09.07.2014 | Niko Braun, MD Robert-Bosch-Hospital, Stuttgart |
Physiology and Pathophysiology of the kidneys |
15.07.2014 | Sara Y. Brucker, MD Medical Director, Dept. of Female Health, University Hospital Tuebingen |
Physiology and Pathophysiology of the breast |
27.10.2014 | Margarida D. Amaral, PhD BioISI, Faculty of Sciences, University of Lisboa, Portugal |
Cystic Fibrosis: Novel Personalized Therapies Targeting the Molecular Defect |
29.10.2014 | Klaus Mörike, MD Dept. of Clinical Pharmacology, University Hospital Tuebingen |
Drug Treatment of Cardiac Arrhythmia |
12.11.2014 | Robert Jütte, Dr. phil. Institute of the History of Medicine, Stuttgart |
The Placebo Effect: Past and Present |
19.11.2014 | Ulrich Lauer, MD Dept. Internal Medicine I, University Hospital Tuebingen |
Virotherapie therapiefraktärer Tumorerkrankungen |
21.11.2014 | Björn Windshügel, PhD Fraunhofer Institut, Hamburg |
Computational Approaches in Nuclear Receptor Research |
26.11.2014 | Walter Aulitzky, MD Dept. of Oncology, Robert-Bosch-Hospital |
Anticancer Drugs - Mechanisms and Therapy |
04.12.2014 | Julia Schüler Oncotest GmbH, Freiburg |
Oncology Platforms at Oncotest |
10.12.2014 | Reinhold Kerb, MD Medical Director, CRS Clinical Research GmbH, Lübeck |
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome |
2013 | ||
07.01.2013 | Dr. Matthias Haag Institute of Genetics, University of Cologne |
Quantification of Mitochondrial Phospholipids by ESI-MS/MS |
18.01.2013 | Monilola Olayioye, PhD Institute of Cell Biology and Immunology, University of Stuttgart |
ErbB receptors: Novel regulatory mechanisms and signaling crosstalk |
23.01.2013 | Stephan Urban, PhD Department of Molecular Virology, University Hospital Heidelberg |
Entry and entry inhibition of Hepatitis B virus (HBV): The role of sodium taurocholate co-transporting polypeptide (NTCP/SLC10A) as a functional HBV receptor |
18.02.2013 | Friedrich Pürner, MD Women's penitentiary, Aichach |
Medizin hinter Gittern - Alltag ärztlicher Arbeit im Knast |
17.04.2013 | Walter Aulitzky, MD Robert-Bosch-Hospital, Stuttgart |
Introduction - Basic and Clinical Aspects in Oncology |
24.04.2013 | German Ott, MD Robert-Bosch-Hospital, Stuttgart |
Tumor Pathology |
15.05.2013 | Christoph Ulmer, MD Robert-Bosch-Hospital, Stuttgart |
Importance of visceral surgery in metastasis |
29.05.2013 | Birgit Spänkuch, MD University Hospital Tübingen |
The role of Plk1 for the cell cycle in cancer and primary cells |
19.06.2013 | Michael Schwarz, MD University Hospital Tübingen |
Mechanisms of tumor promotion |
19.07.2013 | Saskia de Wildt, MD, PhD Dept. of Surgery and Intensive Care, Erasmus MC Sophia Children's Hospital |
Drug metabolism in children: the interplay of age, disease and genetics |
24.10.2013 | Nico Scheer / John Bial Taconic GmbH, Cologne and Yecuris Portland, USA |
Genetically and liver humanized mouse models and advanced human hepatocytes for improved prediction of the ADMET characteristics of compounds in humans |
06.11.2013 | Christina Justenhoven, PhD Bioscientia, Institute of Medical Diagnostics, Ingelheim |
Analysis of DNA variations |
26.11.2013 | Kerstin Junker, MD University Hospital Saarland |
Molekulargenetische Charakterisierung des Nierenzellkarzinoms zur individuellen Prognosedifferenzierung und Therapiewahl |
2012 | ||
11.01.2012 | Prof. Klaus Mörike Clinical Pharmacology, University Hospital Tübingen |
Drug Therapy in Special Populations: Advanced Age and Pregnancy |
18.01.2012 | Prof. Klaus Mörike Clinical Pharmacology, University Hospital Tübingen |
Drug Therapy of Cardiac Arrhytmia |
19.01.2012 | Dario Cattaneo, PhD Unit of Clinical Pharmacology, "Luigi Sacco" University Hospital, Milan, Italy |
Clinical Pharmacology of antiretroviral drugs |
24.01.2012 | Ludmilla Prokunina-Olsson, PhD Laboratory of Translational Genomics, National Cancer Institute, NIH, Bethedsda, USA |
Genetics of cellular detoxification and its role in bladder cancer susceptibility - the mysterious case of the UGT1A locus |
15.02.2012 | Adriano Henney, PhD Program Director of the German Virtual Liver Network |
Systems approaches to 21st Century Medicine |
22.02.2012 | Prof. Jörn Lötsch Hospital and Faculty of Medicine, Johann Wolfgang Goethe-University, Frankfurt / Main |
Drug therapy against pain: pharmacokinetics, pharmacogenetics, and drug development |
23.03.2012 | Prof. Dr. Werner Mewes Helmholtz Zentrum München; Deutsches Forschungszentrum für Gesundheit und Umwelt |
Systems Biology from Correlation to Causation for Personalized Medicine |
23.04.2012 | Prof. Dr. Marc Reymond Marienhospital Herne, Klinikum der Ruhr-Universität Bochum |
Normotherme Intraperitoneale Aerosol Chemotherapie (NIPAC): ein neuer Ansatz in der Therapie der Peritonealkarzinose |
03.05.2012 | Prof. Dr. Swen Hülsmann Universitätsmedizin Göttingen |
Neuron-Glia-Interaction: Are brainstem astrocytes different? |
29.05.2012 | Dr. Ute Albrecht Universitätsklinikum Düsseldorf |
Crosstalk of mediators: Communication between macrophages and hepatocytes |
05.06.2012 | Prof. Dr. Andreas J. Fallgatter Ärztlicher Direktor der Klinik für Allgemeine Psychiatrie und Psychotherapie mit Poiklinik, Eberhard Karls Universität Tübingen |
Brain functional endophenotypes in Attention Deficit- / Hyperactivity Disorder - a pathway to individualized psychiatry? |
09.10.2012 | Dr. Susann Irgang Max Planck Institut für Molekulare Pflanzenphysiologie, Golm |
Metabolic regulation during the inhibition of the 'Target of rapamycin' Kinase in Chlamydomonas reinhadtii |
29.10.2012 | Dipl. Biochem. Stefanie Schmidt Max Planck Institut für Molekulare Pflanzenphysiologie, Golm |
Reil mediated leaf development in the cold |
29.11.2012 | Prof. Dr. Guenter Schwarz Institute of Biochemistry, Department of Chemistry & Center for Molecular Medicine, University of Cologne |
Biochemistry of Molybdenum: Pathways, Enzymes, and neurodegenerative Diseases |
11.12.2012 | Dr. Florian Schröder Max Planck Institut für Molekulare Pflanzenphysiologie, Golm |
Brassinosteroid-dependet leaf growth |
2011 | ||
19.01.2011 | PD Dr. Peter Bauer Medical Genetics, University of Tuebingen |
Next Generation-Sequencing for DNA and RNA. |
09.02.2011 | Prof. Dr. Peter Jansen Department of Hepatology, Academic Medical Center, Amsterdam, The Netherlands |
Multidrug Resistance Transporters and miRNAs Expression in Hepatocellular Carcinoma. |
06.04.2011 | PD Dr. Susanne Ammon-Treiber Clinical Pharmacology, University Hospital Tübingen |
The isolated perfused lung as a model in lung pharmacology. |
29.06.2011 | Dr. Niko Braun Robert-Bosch-Hospital, Stuttgart |
Physiology and Pathophysiology of the kidney. |
13.07.2011 | Prof. Dr. Tanja Fehm University Women's Hospital, Tübingen |
Physiology and Pathophysiology of the breast. |
05.08.2011 | Prof. Dr. Leszek Wojnowski University Hospital, Johanns Gutenberg-University Mainz |
CYP3As and their regulators - lessons from the past. |
22.09.2011 | Dr. Nico Scheer Head of ADMET R&D, TaconicArtemis GmbH, Köln |
Humanized mouse models for pharmacokinetic and safety profiling of compounds. |
16.11.2011 | Prof. Dr. Robert Jütte Director of the Insitute for the History of Medicine of the Robert Bosch Foundation, Stuttgart |
The Placebo Effect: Past and Present |
23.11.2011 | Dr. Petra Knupfer Head of the office of the Ethics Committee at the State Medical Chamber of Baden-Wuerttemberg, Stuttgart |
Composition and tasks of Research Ethics Committees (RECs). |
28.11.2011 | Prof. Luc Pellerin Directeur a.i., Department of Physiology, University of Lausanne, Switzerland |
Nuroenergetics: regulations and roles of monocarboxylate transporters |
05.12.2011 | Dr. Peter Stopfer Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach |
Pharmacokinetics in Drug Development |
07.12.2011 | Prof. Christian Harteneck Deputy Head of the Department of Pharmacology and Experimental Therapy (APET), University of Tuebingen |
Pharmacological modulation of ion channels |
14.12.2011 | Dr. Sebastian Graf von Kielmansegg University of Mannheim, Department of German and Foreign Public Law, International Law and European Law |
Legal Regulation of clinical Studies |
2010 | ||
08.03.2010 | Dr. Carina Hellberg Ludwig Institute for Cancer Research, Uppsala, Sweden |
T-cell protein tyrosie phophatase regulates the M2 pyruvate kinase activity. |
31.03.2010 | Dr.-Ing. Jürgen Friedmann Vice-President Corporate Intellectual Property Patents Electronics, Robert Bosch GmbH |
Von der Idee zum Patent |
27.05.2010 | Dr. Manfred Rauh University Hospital Erlangen |
LC-MS/MS in der Steroidanalytik |
25.10.2010 | Prof. Dr. Dietrich Keppler German Cancer Research Center (DKFZ), Heidelberg |
Uptake and Efflux Transporters of Human Hepatocytes. |
2009 | ||
28.01.2009 | Prof. Dr. med. Martin Wehling University Hospital Mannheim |
Nutzenanalyse in Deutschland: Götterdämmerung oder weiter so? |
29.01.2009 | Univ.-Prof. Dr. med. Karsten Schrör University Hospital Düsseldorf |
Pharmakokinetik und Antiplättchenwirkung von Thienopyridine |
23.03.2009 | Prof. Dr. med. Martina Muckenthaler University Hospital Heidelberg |
Regulation of systemic iron homeostasis by miR122a |
05.05.2009 | Prof. Michael S. Phillips, Ph.D Université de Montréal |
Development and optimization of a broad-based ADME genotyping system in clinical trials |
12.05.2009 | Dr. med. Lusine Danielyan University Hospital Tübingen |
Intranasal delivery of cells to the brain |
26.10.2009 | Dr. med. Andreas Benesic Prof. Dr. Alexander L. Gerbes University Hospital Munich Großhadern |
Metaheps - interessante Zellen aus peripheren Monozyten |
29.10.2009 | Dr. Jan Korbel European Molecular Biology Laboratory, Heidelberg |
Global mapping of coy-number variants in humans - approaches and applications |
10.12.2009 | Dr. Carole Devaux, Ph.D. University of Luxembourg |
Collaboration with Africa for HIV and AIDS: Challenges and Opportunities |
2008 | ||
17.01.2008 | Prof. Ramiro Jover University of Valencia, Spain |
Regulation of human cytochrome P450 genes by liver-enriched transcription factors: Application to the development of metabolically competent hepatic cell models |
20.02.2008 | PD Dr. Lütjohann University of Bonn |
Steroidal Marker of Cholesterol and Bile Acid Metabolism |
05.03.2008 | Prof. Dr. Alfons Meindl University Hospital 'rechts der Isar', Munich |
Monogen, heterogen, polygen - Genetische Formen des familiären Mammakarzinoms |
29.04.2008 | Prof V. Craig Jordan Fox Chase Cancer Center, Philadelphia, USA |
Development and Current Role of Tamoxifen and Raloxifen in the Treatment or Prevention of Breast Cancer and Osteoporosis |
11.06.2008 | Dr. Hajo Otten, Patent Lawyer Witte, Welle & Partner, Stuttgart |
Patente und geistiges Eigentum in Medizin und Biotechnologie - eine Einführung |
24.06.2008 | Prof. Dr. Werner Lubitz Universitäy of Vienna, Austra |
Bacterial Ghost Platform Technology |
09.07.2008 | Prof. Jens Schröder University of Schleswig-Holstein |
Antimicrobial Peptides: Local Host Response Elements |
17.07.2008 | Dr. Rene Krieg Bruker Daltronik GmbH |
MALDI Imaging, Molecular Histology and Class Imaging – Novel Techniques for Tissue Based Proteomics |
18.07.2008 | Prof. Paavo Honkakosi University of Kuopio, Finland |
Unraveling the ligand specificity of nuclear receptor CAR |
09.09.2008 | Prof. Lutz Heide University of Tübingen |
Genetic engineering of microorganisms for the generation of new antibiotics |
15.09.2008 | Dr. Jörg Lippert Bayer Technology Services GmbH |
Mechanistische Modellierung und Ihre Anwendungen in der klinischen Pharmakologie |
29.09.2008 | Professor Amin Rostami-Hodjegan University of Sheffield, UK |
Systems Pharmacology: Putting Things Together |
10.10.2008 | Prof. Jose Pedro Gil Karolinska Institute, Sweden |
Artemisin derivative combination therapy – a malaria chemotherapy under global implementation |
17.10.2008 | Prof. Meinhard Kieser University Hospital Heidelberg |
Fallzahlberechnung unter Unsicherheit - Welche Möglichkeiten bieten flexible Studiendesigns? |